CA2403349A1 - Preparation of particles for inhalation - Google Patents
Preparation of particles for inhalation Download PDFInfo
- Publication number
- CA2403349A1 CA2403349A1 CA002403349A CA2403349A CA2403349A1 CA 2403349 A1 CA2403349 A1 CA 2403349A1 CA 002403349 A CA002403349 A CA 002403349A CA 2403349 A CA2403349 A CA 2403349A CA 2403349 A1 CA2403349 A1 CA 2403349A1
- Authority
- CA
- Canada
- Prior art keywords
- particles
- particle
- surfactant
- formation
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title abstract 13
- 239000004094 surface-active agent Substances 0.000 abstract 5
- 230000015572 biosynthetic process Effects 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- -1 poly(lactic acid) Polymers 0.000 abstract 4
- 229940124597 therapeutic agent Drugs 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 abstract 2
- 229920000954 Polyglycolide Polymers 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 150000002327 glycerophospholipids Chemical class 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000747 poly(lactic acid) Polymers 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm3 and a mass mean diameter between 5 µm and 30 µm, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant. Surfactants can be incorporated on the particle surface for example by coating the particle after particle formation, or by incorporating the surfactant in the material forming the particle prior to formation of the particle. Exemplary surfactants include phosphoglycerides such as dipalmitoyl phosphatidylcholine (DPPC). The particles can be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of a wide variety of therapeutic agents. Formation of complexes of positively or negatively charged therapeutic agents with molecules of opposite charge can allow control of the release rate of the agents into the bloodstream following administration.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US784,421 | 1997-01-16 | ||
| US08/784,421 US5855913A (en) | 1997-01-16 | 1997-01-16 | Particles incorporating surfactants for pulmonary drug delivery |
| US5900497P | 1997-09-15 | 1997-09-15 | |
| US60/059,004 | 1997-09-15 | ||
| CA002277801A CA2277801C (en) | 1997-01-16 | 1997-11-17 | Preparation of particles for inhalation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002277801A Division CA2277801C (en) | 1997-01-16 | 1997-11-17 | Preparation of particles for inhalation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2403349A1 true CA2403349A1 (en) | 1998-07-23 |
| CA2403349C CA2403349C (en) | 2008-01-29 |
Family
ID=27170986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002403349A Expired - Lifetime CA2403349C (en) | 1997-01-16 | 1997-11-17 | Preparation of particles for inhalation |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2403349C (en) |
-
1997
- 1997-11-17 CA CA002403349A patent/CA2403349C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2403349C (en) | 2008-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2277801A1 (en) | Preparation of particles for inhalation | |
| CA2336139A1 (en) | Large porous particles emitted from an inhaler | |
| DE69930240T2 (en) | MATRIZES MADE OF POLYMER AND HYDROPHOBIC COMPOUNDS FOR USE IN THE DISPOSAL OF MEDICINAL PRODUCTS | |
| EP1128813B1 (en) | An inhalation system | |
| CA2060176C (en) | Small particle drug compositions | |
| AU709240B2 (en) | Microcapsules, method of making and their use | |
| EP1000615B1 (en) | Preparation of pharmaceutically active particles | |
| US8440231B2 (en) | Swellable particles for drug delivery | |
| JP2006503865A (en) | Sustained release porous microparticles for inhalation | |
| JP2002518432A5 (en) | ||
| US7138136B2 (en) | Agglomerated particles for aerosol drug delivery | |
| JP2006513236A (en) | Pharmaceutical formulations with insoluble active substances | |
| JP2006511617A (en) | Pharmaceutical porous particles | |
| CA2403349A1 (en) | Preparation of particles for inhalation | |
| Boddu et al. | Nanocarrier systems for lung drug delivery | |
| Cheow et al. | Preparations of dry-powder therapeutic nanoparticle aerosols for inhaled drug delivery | |
| Sonvico et al. | Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies | |
| Manca | Chitosan and PLGA microspheres as drug delivery system against pulmonary mycobacteria infections | |
| Mobley | in the Design of Pulmonary Drug Delivery Systems | |
| Ichikawa et al. | 4.4 Design and Formation of Composite Particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20171117 |